The business model for antibiotics is broken
Kevin Outterson April 9, 2014
High volume sales of antibiotics drive evolutionary resistance. So why do we allow most of the supply chain to make money based on the volume
High volume sales of antibiotics drive evolutionary resistance. So why do we allow most of the supply chain to make money based on the volume
Several weeks ago I quoted an article claiming that “90% of papers that have been published in academic journals are never cited.” As I wrote,
If RAND’s latest report is accurate, the uninsured rate among 18-64 year old adults in the United States fell by 23 percent—from 20.5 percent to 15.8
Starting as early as today, CMS will publicly release comprehensive data on physician billing practices in Medicare, including information about specific, identifiable doctors. The move
Work posted here under copyright © of the authors • Details on the Site Policies page
